Raseglurant

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRaseglurant
Drug Alias NameADX-10059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsMigraine DisordersGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Pharma Sa
Active IndicationsN/A
Inactive IndicationsMigraine DisordersGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksDrugBank